vs

Side-by-side financial comparison of Ameris Bancorp (ABCB) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Ameris Bancorp is the larger business by last-quarter revenue ($314.4M vs $197.9M, roughly 1.6× REPLIGEN CORP). Ameris Bancorp runs the higher net margin — 35.1% vs 6.7%, a 28.4% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 10.0%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 2.3%).

Ameris Bancorp is an American bank holding company headquartered in Atlanta, Georgia. Through its bank subsidiary, Ameris Bank, the company operates full-service branches in Georgia, Alabama, Florida, North Carolina and South Carolina, and mortgage-only locations in Georgia, Alabama, Florida, North Carolina, South Carolina, Virginia, Maryland, and Tennessee. The company offers online and mobile banking options for both consumers and businesses.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

ABCB vs RGEN — Head-to-Head

Bigger by revenue
ABCB
ABCB
1.6× larger
ABCB
$314.4M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+3.7% gap
RGEN
13.6%
10.0%
ABCB
Higher net margin
ABCB
ABCB
28.4% more per $
ABCB
35.1%
6.7%
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
2.3%
ABCB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ABCB
ABCB
RGEN
RGEN
Revenue
$314.4M
$197.9M
Net Profit
$110.5M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
35.1%
6.7%
Revenue YoY
10.0%
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$1.63
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCB
ABCB
RGEN
RGEN
Q1 26
$314.4M
Q4 25
$307.1M
$197.9M
Q3 25
$314.2M
$188.8M
Q2 25
$300.7M
$182.4M
Q1 25
$285.9M
$169.2M
Q4 24
$290.8M
$174.1M
Q3 24
$283.8M
$154.9M
Q2 24
$300.6M
$154.1M
Net Profit
ABCB
ABCB
RGEN
RGEN
Q1 26
$110.5M
Q4 25
$108.4M
$13.3M
Q3 25
$106.0M
$14.9M
Q2 25
$109.8M
$14.9M
Q1 25
$87.9M
$5.8M
Q4 24
$94.4M
$-30.3M
Q3 24
$99.2M
$-654.0K
Q2 24
$90.8M
$3.3M
Gross Margin
ABCB
ABCB
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
ABCB
ABCB
RGEN
RGEN
Q1 26
Q4 25
45.9%
9.0%
Q3 25
43.6%
8.9%
Q2 25
47.4%
7.6%
Q1 25
39.5%
3.9%
Q4 24
43.3%
-17.7%
Q3 24
44.4%
-5.1%
Q2 24
42.1%
1.0%
Net Margin
ABCB
ABCB
RGEN
RGEN
Q1 26
35.1%
Q4 25
44.2%
6.7%
Q3 25
33.7%
7.9%
Q2 25
36.5%
8.2%
Q1 25
30.8%
3.4%
Q4 24
42.5%
-17.4%
Q3 24
35.0%
-0.4%
Q2 24
30.2%
2.2%
EPS (diluted)
ABCB
ABCB
RGEN
RGEN
Q1 26
$1.63
Q4 25
$1.59
$0.24
Q3 25
$1.54
$0.26
Q2 25
$1.60
$0.26
Q1 25
$1.27
$0.10
Q4 24
$1.35
$-0.55
Q3 24
$1.44
$-0.01
Q2 24
$1.32
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCB
ABCB
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$4.1B
$2.1B
Total Assets
$28.1B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCB
ABCB
RGEN
RGEN
Q1 26
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Total Debt
ABCB
ABCB
RGEN
RGEN
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
ABCB
ABCB
RGEN
RGEN
Q1 26
$4.1B
Q4 25
$4.1B
$2.1B
Q3 25
$4.0B
$2.1B
Q2 25
$3.9B
$2.1B
Q1 25
$3.8B
$2.0B
Q4 24
$3.8B
$2.0B
Q3 24
$3.7B
$2.0B
Q2 24
$3.6B
$2.0B
Total Assets
ABCB
ABCB
RGEN
RGEN
Q1 26
$28.1B
Q4 25
$27.5B
$2.9B
Q3 25
$27.1B
$2.9B
Q2 25
$26.7B
$2.9B
Q1 25
$26.5B
$2.9B
Q4 24
$26.3B
$2.8B
Q3 24
$26.4B
$2.8B
Q2 24
$26.5B
$2.9B
Debt / Equity
ABCB
ABCB
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCB
ABCB
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCB
ABCB
RGEN
RGEN
Q1 26
Q4 25
$390.2M
$25.7M
Q3 25
$104.9M
$48.1M
Q2 25
$61.4M
$28.6M
Q1 25
$116.9M
$15.0M
Q4 24
$154.2M
$39.2M
Q3 24
$102.2M
$49.3M
Q2 24
$-97.1M
$42.2M
Free Cash Flow
ABCB
ABCB
RGEN
RGEN
Q1 26
Q4 25
$369.6M
$17.6M
Q3 25
$100.5M
$43.4M
Q2 25
$53.7M
$21.5M
Q1 25
$114.2M
$11.4M
Q4 24
$140.7M
$33.6M
Q3 24
$99.8M
$42.3M
Q2 24
$-100.3M
$37.4M
FCF Margin
ABCB
ABCB
RGEN
RGEN
Q1 26
Q4 25
120.4%
8.9%
Q3 25
32.0%
23.0%
Q2 25
17.9%
11.8%
Q1 25
39.9%
6.8%
Q4 24
48.4%
19.3%
Q3 24
35.2%
27.3%
Q2 24
-33.4%
24.3%
Capex Intensity
ABCB
ABCB
RGEN
RGEN
Q1 26
Q4 25
6.7%
4.1%
Q3 25
1.4%
2.5%
Q2 25
2.5%
3.9%
Q1 25
0.9%
2.1%
Q4 24
4.6%
3.2%
Q3 24
0.8%
4.5%
Q2 24
1.1%
3.1%
Cash Conversion
ABCB
ABCB
RGEN
RGEN
Q1 26
Q4 25
3.60×
1.93×
Q3 25
0.99×
3.23×
Q2 25
0.56×
1.92×
Q1 25
1.33×
2.57×
Q4 24
1.63×
Q3 24
1.03×
Q2 24
-1.07×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons